Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 55700-996

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 55700-996). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (1)

Label for Tramadol Hydrochloride Extended Release Tablets USP 100 mg, packaged by Quality Care Products, LLC. The label indicates a quantity of 30 tablets, with a controlled substance schedule IV (C-IV) marking, Rx only. Manufactured by Lupin Limited in India for Lupin Pharmaceuticals, Baltimore, Maryland. Storage instructions note 77 degrees F. Includes warnings about habit-forming potential and keeping medication out of reach of children.*

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of tramadol hydrochloride, showing the molecular arrangement including a methoxyphenyl group, a cyclohexanol ring, and a dimethylaminoethyl side chain, with a hydrochloride salt indicated.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph showing Tramadol concentration (ng/mL) over 24 hours comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The graph plots concentration on the y-axis and time in hours on the x-axis, with distinct lines and markers for each formulation.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis shows time in hours, and the y-axis shows M1 concentration. Two curves represent the concentration profiles of the two formulations over time.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving response versus response threshold (percent improvement from baseline). It compares response rates for Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, 400 mg doses, and a placebo group. The graph illustrates trends in patient response at increasing levels of pain improvement threshold.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis Patients Achieving Various Levels of Response Threshold' shows the percent of patients achieving response on the Y-axis versus response threshold (percent improvement from baseline) on the X-axis. Two lines are plotted: one for Tramadol Hydrochloride Extended-Release Tablets and one for Placebo, with the tramadol line consistently above the placebo line across response thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.